1. Introductory Text

2. Article 1. Subject matter

3. Article 2. Definitions

4. Article 3. Existing Active Substances

5. Article 4. Non-inclusion

6. Article 4a. Essential use

7. Article 4b. Extension of deadline for placing on the market

8. Article 5. Review of notified existing active substances

9. Article 6. Preparation of the complete dossier

10. Article 7. Submission of the complete dossier

11. Article 8. Joining, replacing or withdrawal of participants

12. Article 9. Completeness check of dossiers

13. Article 10. Evaluation of dossiers by the Rapporteur Member State

14. Article 11. Commission procedures

15. Article 12. . . . . . . . . . ....

16. Article 13. Suspension of procedures

17. Article 14. Amendments to Regulation (EC) No 1896/2000

18. Article 15. Entry into force

19. Signature

20. 1. ANNEX I

       EXISTING ACTIVE SUBSTANCES

       1. . . . . . . . . . ....

    2. ANNEX II

       EXISTING ACTIVE SUBSTANCES AND PRODUCT TYPES INCLUDED IN THE REVIEW PROGRAMME

       1. . . . . . . . . . ....

    3. ANNEX III

       EXISTING ACTIVE SUBSTANCES THAT HAVE BEEN IDENTIFIED BUT IN RESPECT OF WHICH NO NOTIFICATION HAS BEEN ACCEPTED OR NO MEMBER STATE HAS INDICATED AN INTEREST AND EXISTING ACTIVE SUBSTANCES THAT HAD BEEN NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH NO PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANT

       1. . . . . . . . . . ....

    4. ANNEX IV

       REQUIREMENTS FOR THE COMPLETE DOSSIER AND THE SUMMARY DOSSIER

       1. (a) . . . . . . . . . ....

       2. (b) The summary dossier must include the following:

       3. (c) . . . . . . . . . ....

       4. (d) . . . . . . . . . ....

    5. ANNEX V

       TIME PERIODS AND RAPPORTEUR MEMBER STATES FOR THE SUBMISSION OF COMPLETE DOSSIERS FOR EXISTING ACTIVE SUBSTANCES INCLUDED IN THE REVIEW PROGRAMME

       1. Part A

       2. Part B

       3. Part C

       4. Part D

    6. ANNEX VI

       COMPETENT AUTHORITIES, AS REFERRED TO IN ARTICLE 5(4) AS OF 1 MARCH 2005

       1. BELGIUM

       2. CZECH REPUBLIC

       3. DENMARK

       4. GERMANY

       5. ESTONIA

       6. GREECE

       7. SPAIN

       8. FRANCE

       9. IRELAND

       10. ITALY

       11. CYPRUS

       12. LATVIA

       13. LITUANIA

       14. LUXEMBOURG

       15. HUNGARY

       16. MALTA

       17. NETHERLANDS

       18. AUSTRIA

       19. POLAND

       20. PORTUGAL

       21. SLOVENIA

       22. SLOVAKIA

       23. FINLAND

       24. SWEDEN

       25. UNITED KINGDOM

       26. ICELAND

       27. NORWAY

    7. ANNEX VII

       EXISTING ACTIVE SUBSTANCES THAT WERE NOT IDENTIFIED BY 28 MARCH 2002 BUT MAY REMAIN ON THE MARKET UNTIL 1 SEPTEMBER 2006

       1. . . . . . . . . . ....

    8. ANNEX VIII

       EXISTING ACTIVE SUBSTANCES THAT WERE NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH ANOTHER PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANT

       1. . . . . . . . . . ....